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Research Article 
INTRODUCTION 
Tuberculosis (TB) is a transmittable disease caused by 
Mycobacterium tuberculosis. Despite medical advance-
ment, tuberculosis is very lethal and is the second most 
frequent cause of death in many countries (WHO, 
2014). The world’s quarter population is infected with 
TB. In the report of WHO (2020), it is estimated that 
about ten million of the people developed TB and 1.4 
million died of it. Most new cases were found in the 
populated nations such as India and China (WHO 
2002; and Raviglione et al., 1995). Due to the global 
emergence of multi-drug resistant (MDR) and exten-
sively drug-resistant (XDR) strains of Mycobacterium 
tuberculosis and totally drug resistant TB, there is an 
urgent need to develop new drugs and strategies to 
fight TB (Singh, 2015). The standard treatment for tu-
berculosis susceptible (non-resistant) is given with first-
line tuberculosis drugs Isoniazid, Rifampicin, 
Pyrizinamide for over two months followed by four or 
more than four months with the combination of Isonia-
zid and Rifampicin (NTCP. 2008). Resistance to first-
line drugs is due to the continuous unlinked chromoso-
mal mutation. It is studied that the development of 
MDR-TB is due to misuse of proper antibiotic treatment 
by patients and unfocused physician observations to 
these patients. Due to a very modern issue associated 
with MDR- TB, the Second line Tuberculosis drugs are 
used (Al-Humadi, 2017). Due to the resistance of My-
cobacterium tuberculosis to first-line drugs, it is manda-
tory to study the potential of second-line drugs and the 
controlling agent to fight against TB. Therefore, the 
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objective of the present study was 1) To find the effect 
of second-line anti-TB drugs on M. tuberculosis strains, 
2) To find the combined effect of second-line anti-TB 
drugs and Piper nigrum against Multi-drug resistant 
strain no. 12, 19 and 21. 
MATERIALS AND METHODS  
Collection of samples  
Fresh seeds of P.nigrum were procured from the botan-
ical garden of Kokan Krushi Vidyapeeth, Dapoli, 
Ratnagiri Maharashtra, India. The initial identification 
was made by referring related literature. The authenti-
cation and identification of seeds were made by Dr. 
R.G. Khandekar at the Department of Horticulture, Ko-
kan Krushi Vidyapeeth, Dapoli, Ratnagiri. Maharashtra, 
India. The final confirmation of P.nigrum was made at 
the “Government of India, Ministry of Environment, For-
est and Climate change, Botanical Survey of India, 
Western Regional Centre, 7, Koregaon, Road, Pune, 
India and the Voucher specimen No. BSI/WRC/100-1/
TECH./2019/53 were deposited in the said repository. 
Extraction  
The ethanolic extract of the Piper nigrum seeds were 
carried out by using Soxhlet extraction method at the 
Department of Zoology S. S & L.S. Patkar College 
Goregaon (west), Mumbai, India. The seeds of P. 
nigrum were crushed in pestle and mortar. The crushed 
powder was weighed and loaded in a porous cellulose 
thimble. The process was further followed by adding 
250 ml ethanol to the round bottom flask. The appa-
ratus was assembled and extraction was carried by 
heating at 55OC. The three cycles of extraction were 
carried out to get the compound.  Solvents were filtered 
through Whatman filter paper No.1. The remaining sol-
vent was evaporated at low pressure using a Rotary 
Vacuum Evaporator at 45⁰C. The resultant compound 
was subjected to the Millipore filter system and finally 
dried in a vacuum desiccator and stored at -20⁰C in a 
refrigerator till further use.  
Purchase of drugs 
The drugs ETH (Ethionamide) (Macleods Pharmaceuti-
cals Ltd) and PAS (Para amino salicylic acid) (Lupin 
Ltd) were purchased following the prescription of Physi-
cian from B.J. Govt Medical College and Sassoon Gen-
eral Hospital, Pune, Maharashtra. 
Procurement of M. tuberculosis strains 
The Mycobacterium tuberculosis strain H37Rv and 
MDR-strains-12, 19 and 21 were provided by the De-
partment of Microbiology, B.J. Govt Medical College 
and Sassoon General Hospital Pune, Maharashtra. The 
experiments were carried out under the supervision of 
Dr. Sujata Dharmshale at the BSL3 TB Laboratory facil-
ity at B.J. Govt Medical College, Pune, Maharashtra. 
One set of media bottles for testing one culture consist-
ed of five Lowenstein-Jensen (LJ) slope- one for neat, 
two for 10-2 and two for 10-4; twelve drug-containing LJ 
slopes- two each for drugs ETH, PAS, Extract, ETH+ 
Extract, PAS+ Extract and ETH + PAS + Extract (one 
each for 10-2 and 10-4 suspensions) and one for PNB 
slope and thus total 18 LJ slopes were used. 
Drug containing media preparation  
The LJ medium was prepared as proposed by Gruft 
(1965). All strains of tuberculosis contained some sub-
population of bacilli that were resistant to anti-TB drugs. 
However, in resistant strains, the proportion of such 
bacilli is considerably higher than the sensitive strains. 
The proportion method was used to calculate the pro-
portion of resistant bacilli present in a strain. Two ap-
propriate dilutions of the bacilli, 10-2 and 10-4 dilutions 
(undiluted = 106 to 108 CFU/ml) were inoculated on 
drug-containing and drug-free media in order to obtain 
countable colonies on both media. The ratio of the 
number of colonies observed on the drug-containing 
media to drug-free medium indicated the proportion of 
resistant bacilli present in the strain. The strain was 
classified as sensitive below a certain proportion 
(critical proportion = 1%); above as resistant. The con-
centration of drugs were 0.2 μg /ml and 40 μg /ml add-
ed to LJ Media with a critical proportion 1% to deter-
mine the effect of  ETH and PAS against mycobacterial 
strains for interpretation of the economical variant. 
RESULTS AND DISCUSSION 
The present study observed that there was no growth 
in standard strain H37Rv and S2 inoculums in drug 
medium as well as in drug-free medium. In Strain 
H37Rv S4 inoculums, around 25 large colonies in drug-
free LJ media were observed. At the same time, no 
growth was reported in drugs containing media and in 
ethanol extract. In MDR strain-12 in S2 inoculums 2+ 
colonies were observed in ETH and 1+ in PAS in drug-
free LJ media. On adding the P. nigrum extract in PAS 
and in ETH, it was observed that the numbers of colo-
nies were reduced in PNS + PAS extract and PNS 
+ETH extract with and without LJ media, indicating the 
sensitivity of P. nigrum against MDR strain, thus con-
firming its anti-tuberculosis potential. The MDR strains- 
19 and 21, the S2 and S4 inoculums incorporated in LJ 
media or without media with ethanolic extract of P. 
nigrum in combination with PAS and ETH also showed 
sensitivity, indicating a positive effect against MDR 
strains 19 and 21 (Table 1). 
 Various traditional plants have shown anti-TB activity. 
It is reported that Emblica officinalis was effective in 
preventing Klebsiella pneumoniae ATCC43816 bacteri-
al colonization with the decrease in the bacterial load 
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(Tasduq et al., 2005). The aqueous extracts of Aca-
lypha indica, Adhatoda vasica, Allium cepa, Allium sa-
tivum, Aloe vera have been reported to have anti-
tuberculosis activity against MDR isolates of M. tuber-
culosis (Gupta et al., 2010). Aqueous extract of With-
ania somnifera (0.01-1.0 mg/mL) had significant effect 
against M. tuberculosis H37Rv whereas, P. tuberosa in 
higher concentration showed no inhibition 
(Periyakaruppan et al., 2012). The plants like Citrullus 
colocynthis (L.) (Leon-Diaz et al., 2010), Plumeria bicol-
our (Changtam et al., 2010), Curcuma longa L. (Mehta 
et al., 2013) have also been reported to have anti-TB 
activity. Alpinia galanga (L.) exhibited anti M.TB activity 
with multiple modes of action (Gupta et al., 2014). Cur-
cuma longa and Nigella sativa, modulated the hepato-
toxic effect of anti-tuberculosis drugs and acetamino-
phen (Eman et al., 2018). Sygizium aromaticum Linn. 
also showed activity against M. tuberculosis (Fadipe et 
al., 2020). Zodape and Bhise, (2017), in their study on 
effect of Aloe vera extract and isoniazid - rifampicin 
drug on M. tuberculosis bacterial (Mtb) Strain -H37rv, 
reported that the Aloe vera had anti-TB potential 
against the H37Rv strain.  
In case of Piper nigrum, Singh et al. (2011) studied its 
properties and constituent piperine and tested against 
multi-drug resistant strains of Mycobacterium tubercu-
losis. They found that piperine has the potential to in-
hibit the growth of M. tuberculosis species. Barua et al. 
(2014) studied the antioxidant and anti-mycobacterial 
activity against P. longum seeds extracts and reported 
that the chloroform extracts have effective activity 
against Micobacterium smegmatis. They found that the 
chloroform extract had the best antioxidant activities 
when compared to hexane, ethyl acetate, ethanol and 
aqueous extract. In our previous study it was found 





















H37Rv   
S1 3+ XX XX XX XX XX XX 
S2 2+ NG NG NG NG NG NG 




NG NG NG NG NG NG 
S4 26 CFU (1+) XX XX XX XX XX XX 
MDR 12 
S1 3+ XX XX XX XX XX XX 
S2 2+ 2+ >50CFU (1+) NG 1+ 
Very Tiny 1+ 
colonies 
Very Tiny 1+ 
colonies 
S2 2+ XX XX XX XX XX XX 
S4 1+ 
<50 CFU  
with contam-
ination 
20mall  CFU 
with contam-
ination 
NG 20  tiny CFU 18 tiny CFU 20 tiny CFU 
S4 1+ XX XX XX XX XX XX 
MDR 19 
S1 3+ XX XX XX XX XX XX 
S2 2+ NG NG NG NG NG NG 
S2 2+ XX XX XX XX XX XX 
S4 1+ NG NG NG  NG NG NG 
S4 1+ XX XX XX XX XX XX 
MDR 21   
S1 3+ XX XX XX XX XX XX 
S2 2+ NG NG NG NG NG NG 
S2 2+ XX XX XX XX XX XX 
S4 1+ NG NG NG NG NG NG 
S4 1+ XX XX XX XX XX XX 
Abbreviations: PNS- Piper nigrum (linn.); ETH- Ethionamide; PAS- Para amino salicylic acid; XX=Not done, 1+= 20-100 colonies, 
2+=>100 colonies, 3+=confluent growth, NG=No Growth (Indicate Sensitivity) S1-Neat inoculums (1× 10-1×108 CFU/ml) inoculated sin-
gle LJ with standard strain; S2- 10-2 & S4 10-4 inoculated with standard strains in duplicates. 
Table 1. Showing the effect of P. nigrum seed extract, and ETH and PAS drugs on different strains of M. tuberculosis. 
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PAS caused hepatic damage in Sprague-dawley rats. 
The seed ethanolic extract of  P. nigrum (L.) showed 
hepatoprotective effect on Sprague-dawley rats; when 
administered to the test groups with ETH and PAS with 
or without combination, it ameliorated the toxic effect of 
the drugs (Zodape and Gaikwad, 2019).  In the present 
study, it was observed that the ethanolic extract of P. 
nigrum did not affect the activity of ETH and PAS with 
or without combination  in vitro. This ethanolic extract 
was found to inhibit the growth of H37Rv strains and 
MDR strains-12, MDR strains 19, and MDR strains 21. 
Thus, P. nigrum can play an important role in liver pro-
tection and can have anti-tuberculosis activity against 
M. tuberculosis. Therefore, this study would serve as a 
baseline model system as new templates in the bio-
prospection and development of new and more effec-
tive plant-based antibiotics to prepare multi-drug thera-
py against M. tuberculosis. 
Conclusion 
The present study found that P. nigrum seed ethanolic 
extract did not affect the activity of the antitubercular 
drug ETH and PAS either independently or in combina-
tion. This seed ethanolic extract alone seemed to have 
the anti-tuberculosis activity against the H37Rv strains. 
It was also observed that P. nigrum had clear cut sensi-
tivity against MDR strains-12, MDR strains 19, and 
MDR strains 21, thereby showing anti-tuberculosis ac-
tivity. Therefore, it is suggested that P. nigrum seed 
ethanolic extract supplementation with ETH and PAS 
drugs may be used in the pharmaceutical industry for 
the manufacture of multi-drugs therapy for combating 
MDR and XDR-TB. 
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